Gene expression panel predicts metastatic‐lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer

Prognostic biomarkers are needed to distinguish patients with clinically localized prostate cancer (PCa) who are at high risk of metastatic progression. The tumor transcriptome may reveal its aggressiveness potential and have utility for predicting adverse patient outcomes. Genomewide gene expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubicz, Rohina, Zhao, Shanshan, Wright, Jonathan L., Coleman, Ilsa, Grasso, Catherine, Geybels, Milan S., Leonardson, Amy, Kolb, Suzanne, April, Craig, Bibikova, Marina, Troyer, Dean, Lance, Raymond, Lin, Daniel W., Ostrander, Elaine A., Nelson, Peter S., Fan, Jian‐Bing, Feng, Ziding, Stanford, Janet L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510189/
https://www.ncbi.nlm.nih.gov/pubmed/28145099
http://dx.doi.org/10.1002/1878-0261.12014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510189/
https://www.ncbi.nlm.nih.gov/pubmed/28145099
http://dx.doi.org/10.1002/1878-0261.12014

Ejemplares similares